Lyu Jin-Xiu, Guo Dan-Dan, Song Yu-Chen, Zhang Man-Ru, Ge Feng-Qin, Zhao Jing, Zhu Hua, Hang Peng-Zhou
Department of Pharmacy, Clinical Medical College, Yangzhou University, Northern Jiangsu People's Hospital, 225001 Yangzhou, Jiangsu, China.
Medical College, Yangzhou University, 225009 Yangzhou, Jiangsu, China.
Rev Cardiovasc Med. 2024 Feb 5;25(2):56. doi: 10.31083/j.rcm2502056. eCollection 2024 Feb.
Myokines are a group of cytokines or polypeptides released from skeletal muscle during exercise. Growing evidence suggests that myokines are associated with the development of cardiovascular disease (CVD). Moreover, several myokines in peripheral blood exhibit dynamic changes in different CVD stages. This review summarizes the potential roles of myokines such as myostatin, irisin, brain-derived neurotrophic factor, mitsugumin 53, meteorin-like, and apelin in various CVD, including myocardial infarction, heart failure, atherosclerosis, hypertension, and diabetes. The association of these myokines with biomarkers currently being used in clinical practice is also discussed. Furthermore, the review considers the emerging role of myokines in CVD and addresses the challenges remaining in translating these discoveries into novel clinical biomarkers for CVD.
肌动蛋白是运动过程中从骨骼肌释放的一组细胞因子或多肽。越来越多的证据表明,肌动蛋白与心血管疾病(CVD)的发生发展有关。此外,外周血中的几种肌动蛋白在不同的CVD阶段呈现动态变化。本综述总结了肌肉生长抑制素、鸢尾素、脑源性神经营养因子、三宅素53、类陨石蛋白和Apelin等肌动蛋白在各种CVD中的潜在作用,包括心肌梗死、心力衰竭、动脉粥样硬化、高血压和糖尿病。还讨论了这些肌动蛋白与目前临床实践中使用的生物标志物的关联。此外,本综述考虑了肌动蛋白在CVD中的新作用,并探讨了将这些发现转化为CVD新型临床生物标志物所面临的挑战。